Substance / Medication

Methylprednisolone aceponate

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

464 trials linked to this intervention

464
Total Trials
78
Recruiting
138
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Occupational exposure to beryllium and cancer risk: a review of the epidemiologic evidence.
Boffetta Paolo, Fryzek Jon P, Mandel Jack S · Crit Rev Toxicol · 2012
PMID: 22276590Meta-Analysis
Incidence of immediate hypersensitivity reaction and serum sickness following administration of Crotalidae polyvalent immune Fab antivenom: a meta-analysis.
Schaeffer Tammi H, Khatri Vaishali, Reifler Liza M et al. · Acad Emerg Med · 2012
PMID: 22320362Meta-Analysis
Systematic review: Progression of beryllium sensitization to chronic beryllium disease.
Seidler A, Euler U, Müller-Quernheim J et al. · Occup Med (Lond) · 2012
PMID: 22705916Meta-Analysis
Cream versus ointment: Randomized single-blinded study on the adherence to treatment with topical methylprednisolone aceponate.
Gregersen Deborah Maria, Peckruhn Melanie, Breternitz-Gruhne Maria et al. · Contact Dermatitis · 2024
PMID: 37960922RCT
Plasmapheresis and RATG-induced serum sickness.
Christiaans Maarten H L, van Hooff Johannes P · Transplantation · 2006
PMID: 16436978RCT

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Methylprednisolone aceponate (substance)
SNOMED CT
708199003
UMLS CUI
C0174938

Clinical Data

This intervention maps to 36 entities in the Ltrl knowledge graph.

20
Conditions
7
Biomarkers
6
Specialists
0
Symptoms
464
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.